|
1
|
Olson SH and Kurtz RC: Epidemiology of
pancreatic cancer and the role of family history. J Surg Oncol.
107:1–7. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li D and Abbruzzese JL: New strategies in
pancreatic cancer: Emerging epidemiologic and therapeutic concepts.
Clin Cancer Res. 16:4313–4318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li L, Li B, Chen D, Liu L, Huang C, Lu Z,
Lun L and Wan X: miR-139 and miR-200c regulate pancreatic cancer
endothelial cell migration and angiogenesis. Oncol Rep. 2015.(Epub
ahead of print).
|
|
4
|
Esencay M, Sarfraz Y and Zagzag D: CXCR7
is induced by hypoxia and mediates glioma cell migration towards
SDF-1α. BMC Cancer. 13:3472013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shen G, Li X, Jia YF, Piazza GA and Xi Y:
Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin.
34:336–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Noman MZ, Buart S, Romero P, et al:
Hypoxia-inducible miR-210 regulates the susceptibility of tumor
cells to lysis by cytotoxic T cells. Cancer Res. 72:4629–4641.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pocock R: Invited review: Decoding the
microRNA response to hypoxia. Pflugers Arch. 461:307–315. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bruning U, Cerone L, Neufeld Z, et al:
MicroRNA-155 promotes resolution of hypoxia-inducible factor 1
alpha activity during prolonged hypoxia. Mol Cell Biol.
31:4087–4096. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu ZY, Bai YN, Luo LX, Wu H and Zeng Y:
Expression of microRNA-150 targeting vascular endothelial growth
factor-A is downregulated under hypoxia during liver regeneration.
Mol Med Rep. 8:287–293. 2013.PubMed/NCBI
|
|
10
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hurley J, Roberts D, Bond A, Keys D and
Chen C: Stem-loop RT-qPCR for microRNA expression profiling.
Methods Mol Biol. 822:33–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and
Dou KF: The down-regulation of Notch1 inhibits the invasion and
migration of hepatocellular carcinoma cells by inactivating the
cyclooxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci.
58:1016–1025. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oh YS, Kim HY, Song IC, Yun HJ, Jo DY, Kim
S and Lee HJ: Hypoxia induces CXCR4 expression and biological
activity in gastric cancer cells through activation of
hypoxia-inducible factor-1α. Oncol Rep. 28:2239–2246.
2012.PubMed/NCBI
|
|
14
|
Srivastava SK, Bhardwaj A, Singh S, et al:
MicroRNA-150 directly targets MUC4 and suppresses growth and
malignant behavior of pancreatic cancer cells. Carcinogenesis.
32:1832–1839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sikand K, Slaibi JE, Singh R, Slane SD and
Shukla GC: miR 488* inhibits androgen receptor expression in
prostate carcinoma cells. Int J Cancer. 129:810–819. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sachdeva M and Mo YY: MicroRNA-145
suppresses cell invasion and metastasis by directly targeting mucin
1. Cancer Res. 70:378–387. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Fei M, Xue G, et al: Elevated
levels of hypoxia-inducible microRNA-210 in pre-eclampsia: New
insights into molecular mechanisms for the disease. J Cell Mol Med.
16:249–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Biswas S, Roy S, Banerjee J, et al:
Hypoxia inducible microRNA 210 attenuates keratinocyte
proliferation and impairs closure in a murine model of ischemic
wounds. Proc Natl Acad Sci USA. 107:6976–6981. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ying Q, Liang L, Guo W, et al:
Hypoxia-inducible microRNA-210 augments the metastatic potential of
tumor cells by targeting vacuole membrane protein 1 in
hepatocellular carcinoma. Hepatology. 54:2064–2075. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu T, Zhao L, Chen W, Li Z, Hou H, Ding L
and Li X: Inactivation of von Hippel-Lindau increases ovarian
cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling
pathway. Int J Mol Med. 33:1236–1242. 2014.PubMed/NCBI
|
